Zofran Lawsuit News: More Than 100 Zofran Birth Defects Claims Now Pending in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
November 18, 2015 (PRLEAP.COM) Business NewsNovember 18, 2015 - Zofran lawsuits (http://www.rxinjuryhelp.com/zofran/lawsuit/) filed over the medication's alleged association with serious birth defects continue to mount in courts around the country. According to a report issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on November 16th, there are currently 112 cases pending in U.S. District Court, District of Massachusetts, where all federally-filed product liability claims involving Zofran and birth defects have been consolidated for the purposes of coordinated pretrial proceedings. (In Re Zofran Products Liability Litigation – MDL 2657)
"Our Firm has been retained by a number of clients who allege that their child's birth defects are connected to pre-natal Zofran exposure, and we continue to receive inquiries from others on a regular basis. The growth of the federal Zofran litigation is not at all surprising," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering Zofran lawsuit evaluations to any family whose child may have been born with a heart birth defect, cleft lip or palate, or any other serious congenital abnormality due to pre-natal Zofran exposure.
Zofran Birth Defects Allegations
Zofran is an anti-nausea medication manufactured by GlaxoSmithKline that is indicated to treat post-operative surgery patients, as well as those undergoing certain cancer treatments. The drug has never been approved to treat nausea and vomiting related to pregnancy, and its inclusion in the U.S. Food & Drug Administration's (FDA) Pregnancy Category B indicates that Zofran's effects on a developing pregnancy have not been well-studied. Nevertheless, an analysis published last December in the American Journal of Obstetrics and Gynecology suggested that as many as one million U.S. women annually have been prescribed Zofran or a generic equivalent for this off-label indication.
When the multidistrict litigation now underway in the District of Massachusetts was established by the JPML on October 13th, only a dozen cases were initially transferred to the proceeding. All of the Zofran lawsuits now pending in the litigation similarly allege that Glaxo concealed data linking Zofran to the development of serious birth defects and failed to provide doctors and patients with information regarding this risk. Plaintiffs also accuse the company of improperly marketing the drug as a safe and effective treatment for morning sickness without FDA approval.
Children who allegedly suffered serious birth defects due to their mother's use of Zofran during the first trimester of pregnancy may be entitled to compensation from GlaxoSmithKline. To find out more about available legal options, please visit Bernstein Liebhard LLP's website, or call the Firm directly at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP